Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Ivenix infusion kits recalled by FDA due to serious manufacturing defect

Lines included in the kits were misassembled and could result in a botched blood transfusion. Due to the risk of serious injury or death, the recall has been designated as Class I.

FDA recalls pediatric breathing kits after eight serious injuries

Endotracheal tubes inside Medline neonatal intubation kits have been deemed too narrow, putting newborn patients at risk for hypoxia. This recall has been given the most serious FDA designation due to the risk of death.

money cybersecurity ransomware health IT data breach hacker

Kettering Health hit with class-action lawsuit weeks after ransomware attack

Law firm Wright & Schulte said they filed a legal complaint on behalf of patients, pointing to the health system’s alleged lack of transparency and negligence in protecting data as the basis for the lawsuit.

money business cash flow dollar

Atraverse Medical raises $29M to support FDA-approved heart tech

The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.

Thumbnail

Bayer seeks FDA approval for gadoquatrane, its latest low-dose GBCA

The investigational agent uses 60% less gadolinium without sacrificing image quality, according to recent clinical trial findings.

virtual reality surgical planning

Could the metaverse be the new radiology education classroom?

According to new data, the simulated virtual environment may be just as effective of a setting as the classroom for problem-based learning. 

merger acquisition M&A business

Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Medicare

Senate unveils budget proposal that ditches House’s radiologist Medicare pay hike

Radiology advocates on Monday said they were "deeply disappointed" with the decision while emphasizing it is still early in the process.